Roswell Park Suggests New Strategy for Controlling Graft vs. Host Disease in Blood/Marrow Transplant Recipients
June 13, 2020
June 13, 2020
BUFFALO, New York, June 13 -- The Roswell Park Comprehensive Cancer Center issued the following news release:
New preclinical work by a team of researchers from Roswell Park Comprehensive Cancer Center's Transplant and Cellular Therapy Program suggests that the risk of developing acute graft vs. host disease (GVHD) during allogeneic blood/marrow transplant (BMT) -- a potentially curative treatment for selected patients with hematologic disorders -- can be decreased using an existing . . .
New preclinical work by a team of researchers from Roswell Park Comprehensive Cancer Center's Transplant and Cellular Therapy Program suggests that the risk of developing acute graft vs. host disease (GVHD) during allogeneic blood/marrow transplant (BMT) -- a potentially curative treatment for selected patients with hematologic disorders -- can be decreased using an existing . . .